Internal Medicine

The once-daily tablet is indicated for adult patients with primary non-familial hyperlipidemia or homozygous familial hypercholesterolemia

An interview with a phase 2 investigator on the the novel drug's potential in a field it wasn't originally designed to treat.

If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.

Increasing OSA severity was associated with increasing markers of obesity.

The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients.

A small study found oral vancomycin prophylaxis prevented C diff infection in thoracic transplant patients.

New nationally-representative data show substance-specific use disorders differ in young persons based on when they first experimented.

Multiple myeloma is currently incurable with many patients experiencing relapses.

An expert offers his perspective on the investigative SLP receptor modulator for atopic dermatitis.

An expert discusses new and emerging therapies for atopic dermatitis.

The Harmony Transcatheter Pulmonary Valve System is designed to treat adult and pediatric patients with pulmonary valve regurgitation.

An expert physician in cardiology and metabolic management walks through a presentation on identifying, addressing, and continually treating for heightened cardiometabolic risk.

A proposed smartphone-based intervention to address hydroxyurea nonadherence was welcomed by a majority of surveyed individuals with sickle cell disease.

A dermatologist discusses some of her most common cosmetic practices and techniques.

The investigators monitored any retinopathy events in hepatitis C patients, including those that were untreated and those being treated with PegIFN/RBV.

On World TB Day, experts from the ALA and CDC reflect on the recent issues of tuberculosis.

Scaling-up HCV screening for all inpatients admitted for psychiatric purposes may be more cost-effective compared with a risk-based approach in high-resource countries.

Older age and higher education level were significantly linked with increased depression scores.

The approval is based on results from Phase 3 trials showing high efficacy in adult and pediatric populations.

As a multi-systemic disorder, Fabry disease can impact the functions of various organs. As a genetic disorder, Fabry can impact the offsprings, parents, and relatives of the patient. Therefore, its effects are far-reaching.

A literature review identifies 3 broad factors that may contribute to bias in pain management of African Americans with SCD.

A single-injection co-formulation of pramlitide and insulin may be a better alternative to separate administrations of both key treatments in adults with T1D, particularly following meals.

A majority of surveyed patients and providers want to continue telemedicine follow-up visits after the pandemic ends.

Many patients with genetic obesity disorder experience resistance to treatment, including intensive lifestyle therapy.

A post-hoc analysis of the AWARD-11 trial indicates that 4.5 mg of dulaglutide was effective in lowering and maintaining A1C levels <7% regardless of baseline levels.